SCI & TECH● LOWJun 16 · Jun 16, 2026, 11:07 AM
Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming Leadership
globenewswire_fr · france
Pluristyx issued Japan patent allowance for next-gen synthetic mRNA, accelerating non-viral, footprint-free iPSC generation for regenerative medicine
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from france
BUSINESS4h agoFrance: TotalEnergies cut-price fuel spikes controversy among rivalsEuroNews [en]WORLD5h agoMarie-Antoinette: France’s last queen and first influencer?France 24 [en]WORLD5h agoAbuse survivors set out demands before meeting Pope Leo in FranceRFI [en]POLITICS7h agoEurope baffled by France's sudden leniency toward Russian oligarch UsmanovLe Monde [en]
More in Sci & Tech
SCI & TECH34m agoAI doesn't have rights or feelings, Microsoft's AI chief saysCBS NewsSCI & TECH43m agoGoogle's DeepMind Institute aims to tackle implications of AGISeeking Alpha TechSCI & TECH1h agoHog in the limelight: On Assam’s pygmy hog programmeThe HinduSCI & TECH1h agoThe White House has an AI oversight plan. But who will do the overseeing?Atlantic Council